Literature DB >> 27023911

Disubstituted naphthyl β-D-xylopyranosides: Synthesis, GAG priming, and histone acetyltransferase (HAT) inhibition.

Karin Thorsheim1, Andrea Persson2, Anna Siegbahn1, Emil Tykesson2, Gunilla Westergren-Thorsson2, Katrin Mani2, Ulf Ellervik3.   

Abstract

Xylosides are a group of compounds that can induce glycosaminoglycan (GAG) chain synthesis independently of a proteoglycan core protein. We have previously shown that the xyloside 2-(6-hydroxynaphthyl)β-D-xylopyranoside has a tumor-selective growth inhibitory effect both in vitro and in vivo, and that the effect in vitro was correlated to a reduction in histone H3 acetylation. In addition, GAG chains have previously been reported to inhibit histone acetyltransferases (HAT). To investigate if xylosides, or the corresponding xyloside-primed GAG chains, can be used as HAT inhibitors, we have synthesized a series of naphthoxylosides carrying structural motifs similar to the aromatic moieties of the known HAT inhibitors garcinol and curcumin, and studied their biological activities. Here, we show that the disubstituted naphthoxylosides induced GAG chain synthesis, and that the ones with at least one free phenolic group exhibited moderate HAT inhibition in vitro, without affecting histone H3 acetylation in cell culture. The xyloside-primed GAG chains, on the other hand, had no effect on HAT activity, possibly explaining why the effect of the xylosides on histone H3 acetylation was absent in cell culture as the xylosides were recruited for GAG chain synthesis. Further investigations are required to find xylosides that are effective HAT inhibitors or xylosides producing GAG chains with HAT inhibitory effects.

Entities:  

Keywords:  Biosynthesis; Glycosaminoglycan; HAT; Inhibitor; Phenol; Proteoglycan; Tumor; Xyloside; β4GalT7

Mesh:

Substances:

Year:  2016        PMID: 27023911     DOI: 10.1007/s10719-016-9662-6

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  40 in total

Review 1.  Chemical biology of histone acetyltransferase natural compounds modulators.

Authors:  Fabrizio Dal Piaz; Antonio Vassallo; Osmany Cuesta Rubio; Sabrina Castellano; Gianluca Sbardella; Nunziatina De Tommasi
Journal:  Mol Divers       Date:  2011-01-01       Impact factor: 2.943

Review 2.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 3.  Functions of site-specific histone acetylation and deacetylation.

Authors:  Mona D Shahbazian; Michael Grunstein
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

4.  Cinnamoyl compounds as simple molecules that inhibit p300 histone acetyltransferase.

Authors:  Roberta Costi; Roberto Di Santo; Marino Artico; Gaetano Miele; Paola Valentini; Ettore Novellino; Anna Cereseto
Journal:  J Med Chem       Date:  2007-03-10       Impact factor: 7.446

Review 5.  New and emerging HDAC inhibitors for cancer treatment.

Authors:  Alison C West; Ricky W Johnstone
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

6.  Inhibition of histone acetyltransferase by glycosaminoglycans.

Authors:  Jo Ann Buczek-Thomas; Edward Hsia; Celeste B Rich; Judith A Foster; Matthew A Nugent
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

7.  Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure.

Authors:  T A Fritz; F N Lugemwa; A K Sarkar; J D Esko
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

8.  Tumor attenuation by 2(6-hydroxynaphthyl)-beta-D-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products.

Authors:  Katrin Mani; Mattias Belting; Ulf Ellervik; Niklas Falk; Gabriel Svensson; Staffan Sandgren; Fang Cheng; Lars-Ake Fransson
Journal:  Glycobiology       Date:  2004-01-12       Impact factor: 4.313

Review 9.  Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.

Authors:  József Tímár; Károly Lapis; József Dudás; Anna Sebestyén; László Kopper; Ilona Kovalszky
Journal:  Semin Cancer Biol       Date:  2002-06       Impact factor: 15.707

Review 10.  KATs in cancer: functions and therapies.

Authors:  A Farria; W Li; S Y R Dent
Journal:  Oncogene       Date:  2015-02-09       Impact factor: 9.867

View more
  1 in total

Review 1.  Recent advances on glycosyltransferases involved in the biosynthesis of the proteoglycan linkage region.

Authors:  Jia Gao; Xuefei Huang
Journal:  Adv Carbohydr Chem Biochem       Date:  2021-11-24       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.